Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Patent
1985-03-27
1987-06-23
Schain, Howard E.
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
530413, 530830, A61K 3514, A61K 3516, C07K 320
Patent
active
046753850
ABSTRACT:
A rapid and simple process for purifying human, bovine and porcine procoagulant protein Factor VIII on a large scale using sequential high performance size exclusion chromatography under, first, low salt concentration conditions and, second, under high salt concentration conditions from reconstituted commercial Factor VIII:C (complexed Factor VIII) concentrate. The chromatographic separation is carried out on a high performance size exclusion chromatographic column packed with porous beads having a particle size of from about 13 to about 35 microns, pore diameters of from about 500 to about 2000 Angstroms and a pore volume of from about 1.0 to about 1.8 ml per gram. The first chromatographic separation is carried in a buffered aqueous solution using the buffered aqueous solution as an eluant. The low molecular weight constituents (impurities) are separated from Factor VIII and the high molecular weight constituents (impurities). A second chromatographic separation may be carried out after Factor VIII has been dissociated in a buffered solution having a concentration of from about 0.25 to about 0.45M calcium ion. The second chromatographic column is packed with some packing as the first column and is eluted with a buffered aqueous solution containing 0.25 to 0.45M calcium ion. In a column of 2.5.times.60 cm, 4 gms of commercial Factor VIII concentrate can be purified in less than two hours. The process is amenable to scale up.
REFERENCES:
patent: 3637489 (1972-01-01), Haller
patent: 3657116 (1972-04-01), Haller
patent: 3920625 (1975-11-01), Anderson et al.
patent: 4069216 (1978-01-01), Shanbrom
patent: 4108603 (1978-08-01), Regnier et al.
patent: 4348315 (1982-09-01), Birger et al.
patent: 4377482 (1983-03-01), Rivier
patent: 4397841 (1983-08-01), Johnson
patent: 4503035 (1985-03-01), Pestka et al.
Paper by Phillip J. Fay et al., "Purification and Characterization of a Highly Purified Human Factor VIII Consisting of a Single Type of Polypeptide Chain", Proc. Natl Acad. Sci., vol. 79, pp. 7200-7204, Dec. 1982.
Bio-Rad Price List J., Jan. 1984 and earlier, pp. 94-99, 88-89 and 5.
T. W. Hearn et al., "HPLC Peptides and Protein", American Laboratory, vol. 14(10), Oct. 1982, pp. 1 et seq.
Abstracts of 4th International Symposium on HPLC of Proteins, Peptides, and Polynucleotides, Dec. 10th-12th, 1984, Baltimore, MD.
Paper Titled "Isolation of Human Factor VIII:C by Preparative High Performance Liquid Chromatography", Dec. 10, 1984.
Paper by T. Hashimoto et al., "High Speed Aqueous Gel-Permeation Chromatography", Journal of Polymer Science: Polymer Physics Ed., vol. 16, 1789-1800 (1978).
Alpha Therapeutic Corporation
Schain Howard E.
LandOfFree
Isolation of human plasma procoagulant protein factor VIII from does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Isolation of human plasma procoagulant protein factor VIII from , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Isolation of human plasma procoagulant protein factor VIII from will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-721882